EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, IVVD: Invivyd Inc

11 Mar 26 15:59
LAST:

1.900

CHANGE:
 0.07		OPEN:
1.830		HIGH:
1.950		ASK:
0.000		VOLUME:
1.91M
CHG(%):
3.83		PREV:
1.830		LOW:
1.780		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
11 Mar 261.8301.9501.7801.9001.91M
10 Mar 261.8902.0401.8301.8303.31M
09 Mar 261.7901.9201.7901.8902.18M
06 Mar 261.7001.8251.6901.8003.0M
05 Mar 261.7601.7851.6101.7402.69M
04 Mar 261.6501.7301.6051.7102.2M
03 Mar 261.6701.7301.6151.6202.35M
02 Mar 261.6101.7501.5801.7201.53M
27 Feb 261.6901.7001.6541.6901.0M
26 Feb 261.7301.7601.6751.7001.24M

PROFILE

Name:Invivyd Inc
About:Invivyd, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's pipeline includes PEMGARDA (pemivibart) injection, a half-life extended investigational monoclonal antibody (mAb) for the prevention of COVID-19 in adults and adolescents; VYD2311, an mAb candidate, which is in preclinical studies for the prevention or treatment of COVID-19; and Adintrevimab that is in phase 2/3 clinical trials for the prevention and treatment of COVID-19. It also has discovery stage candidates for the prevention of seasonal influenza and COVID-19. The company has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies. The company was formerly known as Adagio Therapeutics, Inc. and changed its name to Invivyd, Inc. in September 2022. Invivyd, Inc. was incorporated in 2020 and is headquartered in Waltham, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:1601 Trapelo Road, Waltham, MA, United States, 02451
Website:https://invivyd.com
CIK:0001832038
ISIN:US46187W1071
FIGI:BBG00W4ML039

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-1.13 
Forward P/E:-17.78 
PEG Ratio:0.02 
Price to Sales:8.17 
Price to Book:5.53 
Profit Margin:-2.38 
Operating Margin:-1.28 
Return on Assets:-0.53 
Return on Equity:-1.20 
EPS Ratio:-0.45 
Revenue:46.21M 
Shares:277.06M 
Market Cap:526.42M 

TECHNICAL INDICATORS

MA5:1.833.7%
MA10:1.768.0%
MA20:1.6812.9%
MA50:1.973.7%
MA100:2.078.9%
MA200:1.5125.9%
STO9:66.67
STO14:71.43
RSI14:68.83 
MTM14:0.35
ROC14:0.23 
ATR:0.12 
Week High:2.047.4%
Week Low:1.6118.4%
Month High:2.047.4%
Month Low:1.5025.9%
Year High:3.0761.6%
Year Low:0.46313.0%
Volatility:53.23